EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:143117 - lorlatinib

ChEBI IDCHEBI:143117
ChEBI Namelorlatinib
Stars
DefinitionA cyclic ether that is 16,17-dihydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-15(10H)-one substituted by methyl groups at positions 2 and 10R, and by cyano, amino and fluoro groups at positions 3, 7 and 12 respectively. It is a small molecule inhibitor of ALK and ROS1 kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer.
Last Modified18 March 2019
SubmitterTim Willson
DownloadsMolfile

FormulaC21H19FN6O2
Net Charge0
Average Mass406.421
Monoisotopic Mass406.15535
SMILESC[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21
InChIInChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1
InChIKeyIIXWYSCJSQVBQM-LLVKDONJSA-N

Wikipedia
Roles Classification

ChEBI Ontology
IUPAC Name 
(10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile
INNs  Source
lorlatinib  esWHO MedNet
lorlatinibum  laWHO MedNet
lorlatinib  frWHO MedNet
lorlatinibWHO MedNet
Synonyms  Source
PFE-PKIS 10ChEBI
PF06463922ChEBI
PF-06463922ChemIDplus
loratinibChemIDplus
Brand Name  Source
LorbrenaKEGG DRUG
Manual XrefsDatabases
5P8PDBeChem
DB12130DrugBank
LorlatinibWikipedia
D11012KEGG DRUG
Registry NumbersSources
CAS:1454846-35-5ChemIDplus
Citations